Compare CCO & PRGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CCO | PRGO |
|---|---|---|
| Founded | 1995 | 1887 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Advertising | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.4B |
| IPO Year | 2005 | 2013 |
| Metric | CCO | PRGO |
|---|---|---|
| Price | $2.41 | $11.19 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 5 | 3 |
| Target Price | $2.12 | ★ $19.33 |
| AVG Volume (30 Days) | ★ 9.0M | 4.5M |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 10.28% |
| EPS Growth | ★ 110.81 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,604,140,000.00 | $800,000.00 |
| Revenue This Year | $5.35 | N/A |
| Revenue Next Year | $4.26 | $1.02 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 6.57 | N/A |
| 52 Week Low | $1.00 | $9.23 |
| 52 Week High | $2.43 | $28.44 |
| Indicator | CCO | PRGO |
|---|---|---|
| Relative Strength Index (RSI) | 51.08 | 59.21 |
| Support Level | $2.37 | $10.37 |
| Resistance Level | $2.41 | $11.88 |
| Average True Range (ATR) | 0.02 | 0.51 |
| MACD | 0.00 | 0.13 |
| Stochastic Oscillator | 50.00 | 90.92 |
Clear Channel Outdoor Holdings Inc is a provider of out-of-home advertising solutions. The company offers advertisers an opportunity to reach mass audiences across various high-traffic public spaces, by using its diverse portfolio of assets including roadside billboards, street furniture, and airport displays. Its reportable segments are; America (U.S. operations excluding airports), Airports (U.S. and Caribbean airport operations), and Other. A majority of its revenue is generated from the America segment which generates revenue from the sale of advertising on printed and digital out-of-home advertising displays such as bulletins, posters, street furniture, and others. Geographically, the company generates maximum revenue from the United States followed by Singapore.
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo has divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two-thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.